AstraZeneca Income After Taxes 2010-2024 | AZN

AstraZeneca income after taxes for the twelve months ending September 30, 2024 was $6.500B, a 10.08% increase year-over-year.

  • AstraZeneca annual income after taxes for 2023 was $5.961B, a 81.02% increase from 2022.
  • AstraZeneca annual income after taxes for 2022 was $3.293B, a 2763.48% increase from 2021.
  • AstraZeneca annual income after taxes for 2021 was $0.115B, a 96.34% decline from 2020.

AstraZeneca Income After Taxes 2010-2024 | AZN

  • AstraZeneca annual income after taxes for 2023 was $5.961B, a 81.02% increase from 2022.
  • AstraZeneca annual income after taxes for 2022 was $3.293B, a 2763.48% increase from 2021.
  • AstraZeneca annual income after taxes for 2021 was $0.115B, a 96.34% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B